Previous 10 | Next 10 |
Summary Idorsia’s stock is testing its most important overhead resistance and is trying to break out from its long-term downtrend, a rare situation that could lead to significant upside potential. The company has recently reported strong phase 3 results from one of the most...
Summary In today's issue of the 1-Minute Market Report, I examine the market bounce since the October low, and highlight the areas of the market that are leading the way higher. On Thursday, for every stock that was down, there were 26 that were up. For the first time since August...
Summary While a divided US government may look appealing, there are long-term risks amid resulting gridlock. The longest night belonged to the pollsters and pundits, whose predictions for a “red wave” did not come to fruition. Looking at historical relationships ...
Summary Higher interest rates, a strong dollar, and a weakening consumer hurt so many companies. Even those in the health care services niche are at risk. Align Technology shares show no signs of bottoming yet. Macro uncertainty hits so many ways. You might not think...
Summary In the healthcare provider space, nursing expense is the largest component of salaries, wages, and benefits. Barring another disruptive COVID surge, however, we believe the market for nurses is now coming back into balance. If the reduction in contract labor expense co...
Summary In August, I wrote an article entitled The World Of 4,818 Faces An Uncertain Future. In such an environment, I believe the Health Care sector is worthy of your consideration. In this article, I draw from two pieces of research to explain why this is the case. Initially...
Summary Not everything is negative in this bearish market. The healthcare sector is home to stocks with rosy prospects. Vaxcyte's lead candidate, VAX-24, is believed to be a potential pneumococcal conjugate vaccine. Since the start of the year, bearish sentiment has ...
Summary Attached to the new US Inflation Reduction Act is a multipronged mandate on pharmaceutical companies to limit or lower drug prices. DNA sequencing has especially turbocharged pharmaceutical research, and the cost to use it has steadily fallen. The new law doesn’...
Summary Healthcare industry, especially the large-cap pharmaceutical, biotechnology, and managed healthcare stocks are doing well and outperforming the market. More stocks in THQ’s top 70 percent equity portfolio generated high positive price growth than the number of stock...
Summary The Health Care sector continues to generate alpha in 2022, but not all of its holdings are a source of relative safety. Edwards Lifesciences reported a poor Q3 and slashed guidance. Traders reacted harshly to the EPS miss. The stock still looks on the pricey side but ...
News, Short Squeeze, Breakout and More Instantly...
SPDR Select Sector Fund - Health Care Company Name:
XLV Stock Symbol:
NYSE Market:
2024-07-09 10:20:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-06-29 11:10:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-04-09 09:16:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...